029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
UBD632膀胱癌及膀胱组织组合芯片,附TNM和临床分期,63例/63点
点 数63例 数63
行 数7列 数9
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:UBD632
 
膀胱尿路上皮癌及膀胱组织组合微阵列芯片,包含尿路上皮癌60例,边缘膀胱组织3例,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Bla
-Bladder
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
NAT (*)
TISSUE  ARRAYS UBD632
1
2
3
4
5
6
7
8
9
A
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
B
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
C
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
D
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
E
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
F
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
G
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
BLA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1172MBladderLow-grade urothelial carcinoma*T3N0M0IIIAMalignant4*3*2N
A2251MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant6*4*2N
A3359FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3.5*3.5N
A4458MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant8*7*5N
A5579FBladderLow-grade urothelial carcinoma*T2N0M0IIMalignant10*5*1.5N
A6645FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*2*1.5N
A7770MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*4*4N
A8856FBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant6*5*0.5N
A9982FBladderLow-grade urothelial carcinoma*T1N0M0IMalignant3*3*2.5N
B11077MBladderLow-grade urothelial carcinoma*T1N0M0 IIMalignant*N
B21172MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*5*2.5N
B31242MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant4*3*3N
B41371MBladderLow-grade urothelial carcinoma*T2bN0M0IIMalignant4.5*3*2N
B51450MBladderLow-grade urothelial carcinoma*T1N0M0IMalignant5*3*2N
B61570FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant*N
B71665MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*2*1N
B81778FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant7*5*2N
B91850FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C11938MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant10*8*3N
C22048MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C32173FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
C42267MBladderHigh grade urothelial carcinoma (sparse)*T3N0M0IIIAMalignant7*4*3N
C52371MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant8*7N
C62445FBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant10*7*7N
C72561MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
C82682MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
C92770MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant5*2.5*2.5N
D12852MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant6*5*2N
D22969MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant2.5*2.5*2.5N
D33067MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
D43160FBladderHigh grade urothelial carcinoma (degeneration)*T3bN0M0IIIAMalignant3*2N
D53243FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D63360MBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant3*2*2N
D73435MBladderHigh grade urothelial carcinoma*T2aN0M0IIMalignant*N
D83542MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
D93665MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant3*3*1N
E13750MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E23865MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant2*2*1N
E33944MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E44070MBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant5*4*3N
E54142MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1N
E64272MBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
E74358MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant*N
E84479MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant4*3N
E94560FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant5.0N
F14653MBladderHigh grade urothelial carcinoma*T3N2M0IIIBMalignant*N
F24756MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F34853MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant5*4*2N
F44933MBladderHigh grade urothelial carcinoma*T3N1M0IIIAMalignant*N
F55065FBladderHigh grade urothelial carcinoma*T3aN0M0IIIAMalignant4*3*2N
F65168MBladderHigh grade urothelial carcinoma*T3bN0M0IIIAMalignant*N
F75274MBladderHigh grade urothelial carcinoma*T3N0M0IIIAMalignant*N
F85377FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant2*1.5*1N
F95466MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*3*2N
G15537FBladderHigh grade urothelial carcinoma*T2bN0M0IIMalignant*N
G25645FBladderHigh grade urothelial carcinoma*T1N0M0IMalignant*N
G35755MBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*1.5N
G45825FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant13*10*8N
G55970FBladderHigh grade urothelial carcinoma*T2N0M0IIMalignant3*2*2N
G66066MBladderHigh grade urothelial carcinoma (sparse)*T2N0M0IIMalignant*N
G76154MBladderAdjacent normal bladder tissue***NAT*N
G86240FBladderAdjacent normal bladder tissue***NAT*N
G96345MBladderAdjacent normal bladder tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情